ArticleNagoya journal of medical science2024
Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer.
Koki Nakanishi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.